Read + Share
Amedeo Smart
Independent Medical Education
Yadav MP, Ballal S, Sahoo RK, Tripathi M, et al. Long-term outcome of 177Lu-PSMA-617 radioligand therapy in heavily pre-treated metastatic castration-resistant prostate cancer patients. PLoS One 2021;16:e0251375.PMID: 33970962
Email
LinkedIn
Facebook
Twitter
Privacy Policy